» Articles » PMID: 34342866

To Assess the Efficacy of Safety Measures Adopted During Endoscopy in the Corona Virus Disease-19 Era for Health Care Professionals-A Single-centre Tertiary Care Hospital Experience

Abstract

Background And Objectives: During Corona Virus Disease-19 (COVID-19) pandemic, it has been estimated that approximately 10% of health care professionals (HCPs) have been diagnosed contacting  COVID-19. Aerosol-generating procedures have led to change in safety practices among HCPs. We thus evaluated the efficacy of the endoscopic safety measures among HCPs posted in the endoscopy unit.

Methods: In this retrospective analysis, all endoscopic procedures performed over a period of 4 months, from 1 April to 31 July 2020 were included. We noted indications and number of COVID-positive procedures as well as comprehensive screening of HCPs posted in our endoscopy unit. The aim of the study was to evaluate the incidence and outcome of COVID-19 among HCPs.

Results: Three thousand four hundred and sixty procedures were included in the analysis. Indications were divided as urgent (n = 190, 5.49%), semi-urgent (n = 553, 16%) and non-urgent group (n = 2717, 78.52%). Thirty-four procedures (0.98%) were done on diagnosed COVID-19 patients. The most common indications were gastrointestinal bleed (n = 12/34, 35.30%) followed by biliary sepsis (n = 9/34, 26.5%). Among the HCPs, the incidence of symptomatic COVID-19 was 6.58% (n = 5/76). All HCPs recovered with excellent outcomes. A comprehensive screening showed 7.90% (n = 6/76) HCPs having Immunoglobulin G (IgG) antibody in their sera.

Conclusion: Addition of safety measures in endoscopy leads to low risk of transmission among HCPs.

Citing Articles

[COVID-19 and endoscopy services].

Hollerbach S, Rommele C, Muzalyova A, Messmann H Gastroenterologe. 2022; 17(1):22-33.

PMID: 35035585 PMC: 8749920. DOI: 10.1007/s11377-021-00582-8.


Editorial commentary on Indian Journal of Gastroenterology-July-August 2021.

Limdi J Indian J Gastroenterol. 2021; 40(4):349-352.

PMID: 34131868 PMC: 8205649. DOI: 10.1007/s12664-021-01205-4.

References
1.
Zhao J, Yuan Q, Wang H, Liu W, Liao X, Su Y . Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019. Clin Infect Dis. 2020; 71(16):2027-2034. PMC: 7184337. DOI: 10.1093/cid/ciaa344. View

2.
Workman A, Welling D, Carter B, Curry W, Holbrook E, Gray S . Endonasal instrumentation and aerosolization risk in the era of COVID-19: simulation, literature review, and proposed mitigation strategies. Int Forum Allergy Rhinol. 2020; 10(7):798-805. DOI: 10.1002/alr.22577. View

3.
Remuzzi A, Remuzzi G . COVID-19 and Italy: what next?. Lancet. 2020; 395(10231):1225-1228. PMC: 7102589. DOI: 10.1016/S0140-6736(20)30627-9. View

4.
Goenka M, Afzalpurkar S, Ghoshal U, Guda N, Reddy N . Impact of COVID-19 on gastrointestinal endoscopy practice in India: a cross-sectional study. Endosc Int Open. 2020; 8(7):E974-E979. PMC: 7302931. DOI: 10.1055/a-1181-8391. View

5.
Leung N, Chu D, Shiu E, Chan K, McDevitt J, Hau B . Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. 2020; 26(5):676-680. PMC: 8238571. DOI: 10.1038/s41591-020-0843-2. View